Managing health care

Managing health care

The recent revelation that data, previously used to support the use of bone marrow transplantation, had been falsified brings into question the legitimate role of this technology. This article suggests ways in which the purchasers can improve overall quality of care by holding transplant programs ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Compensation & Benefits Management 2000-07, Vol.16 (3), p.46
Hauptverfasser: John M Burns, Joanne Miller, Miller, Laird
Format: Artikel
Sprache:eng
Schlagworte:
Accountability
Beneficiaries
Bone marrow
Breast cancer
Cancer therapies
Chemotherapy
Clinical trials
Employee benefits
Guidelines
Health care
Laboratories
Metastasis
Monetary incentives
Mortality
Patients
Physicians
Prices
Quality of life
Reimbursement
Stem cell transplantation
Toxicity
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The recent revelation that data, previously used to support the use of bone marrow transplantation, had been falsified brings into question the legitimate role of this technology. This article suggests ways in which the purchasers can improve overall quality of care by holding transplant programs accountable. Some guidelines to be used in the selection of transplant programs are discussed.
ISSN:0748-061X